Diametric Capital, LP Poseida Therapeutics, Inc. Transaction History
Diametric Capital, LP
- $205 Million
- Q3 2025
Shares
1 transactions
Others Institutions Holding PSTX
# of Institutions
5Shares Held
5.34MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL299KShares$2.84 Million0.0% of portfolio
-
Cigogne Management Sa Luxembourg, N4120KShares$1.14 Million0.68% of portfolio
-
Rothschild Investment Corp12KShares$114,0000.0% of portfolio
-
Antonetti Capital Management LLC400Shares$3,8000.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...